首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Effect of CYP3A1(23) Induction on Clarithromycin Pharmacokinetics in Rats with Diabetes Mellitus
【2h】

Effect of CYP3A1(23) Induction on Clarithromycin Pharmacokinetics in Rats with Diabetes Mellitus

机译:CYP3A1(23)诱导对糖尿病大鼠克拉霉素药代动力学的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

After intravenous and oral administration of clarithromycin at a dose of 20 mg/kg of body weight to rats with diabetes mellitus induced by alloxan (DMIA) and diabetes mellitus induced by streptozotocin (DMIS), the area under the curve values were significantly smaller than those of respective control rats. The in vitro intrinsic clearance values for the disappearance of clarithromycin were significantly faster in both rats with DMIA and rats with DMIS than in control rats. The above data suggested that metabolism of clarithromycin increased in both types of diabetic rat due to an increase in the expression and mRNA level of CYP3A1(23) in the rats.
机译:对由四氧嘧啶(DMIA)诱导的糖尿病和链脲佐菌素(DMIS)诱导的糖尿病的大鼠静脉和口服给予克拉霉素剂量为20 mg / kg体重后,曲线下面积显着小于那些分别的对照大鼠。 DMIA大鼠和DMIS大鼠的体内克拉霉素消失的体外固有清除率值均明显快于对照大鼠。上述数据表明,两种类型的糖尿病大鼠中克拉霉素的代谢均增加,这是由于大鼠中CYP3A1(23)的表达和mRNA水平的升高所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号